Skip to main content
. 2014 Jul 8;15:108. doi: 10.1186/1471-2369-15-108

Table 1.

Characteristics of CKD and non-CKD participants in NHANES 1999-2004

Variable CKD
Non-CKD
P-value**
(N = 2153) (N = 9433)
Age, years (mean ± SE)
60.7 (0.7)
43.9 (0.3)
<0.001
Male gender, % (SE)
43.1 (1.0)
50.6 (0.4)
<0.001
Race, % (SE)
 
 
0.004
  Non-Hispanic White
71.9 (2.1)
72.4 (1.6)
 
  Non-Hispanic Black
10.8 (1.2)
9.9 (0.9)
 
  Mexican American
5.6 (1.0)
7.6 (0.9)
 
  Other Hispanic
5.8 (1.4)
5.8 (1.1)
 
  Other
5.8 (1.0)
4.2 (0.4)
 
Smoking, % (SE)
18.7 (1.1)
25.6 (0.8)
<0.001
Income, % (SE)
 
 
<0.001
  Missing
11.0 (1.0)
9.0 (0.6)
 
  <20,000
26.3 (1.8)
15.0 (0.8)
 
  20,000-45,000
30.1 (1.4)
26.5 (1.0)
 
  45,000-75,000
18.4 (1.6)
23.4 (0.8)
 
  > = 75,000
14.2 (1.5)
26.1 (1.4)
 
BMI (mean ± SE)
29.2 (0.3)
28.1 (0.1)
<0.001
Waist circumference (cm) (mean ± SE)
101.1 (0.6)
96.1 (0.3)
<0.001
Total fat kg (mean ± SE)*
30.3 (0.4)
28.1 (0.2)
<0.001
Total lean mass excluding BMC kg (mean ± SE)*
49.1 (0.4)
51.2 (0.2)
<0.001
Percent body fat (mean ± SE)*
36.7 (0.2)
33.8 (0.1)
<0.001
eGFR, ml/min/1.73 m2 (mean ± SE)
72.9 (0.9)
96.8 (0.4)
<0.001
UACR (mg/g) (mean ± SE)
154.4 (15.4)
7.1 (0.08)
<0.001
C-reactive protein (mg/dL)
0.59 (0.03)
0.39 (0.009)
<0.001
Hypertension (SBP >140 or DBP >90 mm Hg) or use of antihypertensives
62.4 (1.6)
25.2 (0.8)
<0.001
Diabetes
20.4 (1.4)
4.6 (0.2)
<0.001
Hyperlipidemia
67.9 (1.5)
52.8 (0.8)
<0.001
Liver condition
3.7 (0.5)
3.1 (0.2)
0.07
Cancer,% (SE)
16.1 (1.1)
6.6 (0.3)
<0.001
Physical activity,% (SE)
 
 
<0.001
  LTPA <450 METS/week
67.0 (1.7)
53.7 (1.1)
 
  LTPA 450–749.9 METS/week
8.7 (0.8)
9.1 (0.4)
 
  LTPA ≥750 METS/week
24.3 (1.5)
37.2 (1.0)
 
Sodium intake mg (mean ± SE)*** 3011 (45) 3549 (30) <0.001

*Means and standard errors from survey means on each of the 5 imputations analyzed using procmianalyze.

**Rao-Scott Chi-square test for categorical variables and t-test for continuous variables.

***Sodium available for 2035 and 8095 CKD and non CKD participants respectively.